Jefferies Financial Group restated their buy rating on shares of Primary Health Properties (LON:PHP – Free Report) in a research note released on Friday,Digital Look reports. The firm currently has a GBX 118 target price on the real estate investment trust’s stock.
Several other research firms also recently issued reports on PHP. Shore Capital Group reaffirmed a “house stock” rating on shares of Primary Health Properties in a research note on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a GBX 115 price objective on shares of Primary Health Properties in a report on Thursday, June 25th. Berenberg Bank reissued a “buy” rating and issued a GBX 128 price objective on shares of Primary Health Properties in a research report on Thursday. JPMorgan Chase & Co. raised their target price on Primary Health Properties from GBX 100 to GBX 105 and gave the company a “neutral” rating in a research note on Wednesday, April 8th. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a GBX 105 target price on shares of Primary Health Properties in a research report on Wednesday, April 15th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Primary Health Properties currently has an average rating of “Moderate Buy” and an average price target of GBX 114.20.
Check Out Our Latest Stock Report on PHP
Primary Health Properties Trading Down 2.1%
Primary Health Properties (LON:PHP – Get Free Report) last posted its earnings results on Thursday, July 30th. The real estate investment trust reported GBX 3.80 EPS for the quarter. Primary Health Properties had a net margin of 43.30% and a return on equity of 6.20%. Analysts expect that Primary Health Properties will post 7.0875912 EPS for the current fiscal year.
More Primary Health Properties News
Here are the key news stories impacting Primary Health Properties this week:
- Positive Sentiment: Analysts maintain bullish outlook: Jefferies reaffirmed its “buy” rating and set a GBX 118 price target, while Deutsche Bank also reiterated “buy” with a GBX 115 target. Both targets imply meaningful upside from recent trading levels. Digital Look broker ratings
- Positive Sentiment: Further broker support: Berenberg reaffirmed its “buy” rating and raised or maintained a GBX 128 price target, the most optimistic target among the latest broker updates. Shore Capital also reaffirmed its “house stock” rating. Digital Look broker ratings
- Positive Sentiment: Earnings benefited from the Assura combination: Primary Health Properties reported quarterly earnings of GBX 3.80 per share, with a 45.95% net margin and 6.03% return on equity. The earnings increase following the Assura combination provides evidence of greater scale and supports the investment case for the enlarged healthcare-property portfolio. Primary Health Properties earnings jump after Assura combination
- Neutral Sentiment: Additional research coverage: Edison issued a new report on Primary Health Properties, potentially giving investors further analysis of the company’s prospects after the Assura transaction. The article details were not provided, so its specific earnings or valuation implications are unclear. Edison report on Primary Health Properties
About Primary Health Properties
PHP is a leading investor in critical healthcare infrastructure in the UK and Ireland.
The overall objective of the group is to create progressive returns to shareholders through a combination of earnings growth and capital appreciation. PHP has an unbroken 30 year track record of dividend growth.
To achieve this, PHP invests in healthcare real estate let on long-term leases, backed by secure underlying covenants where the majority of rental income is funded directly or indirectly by a government body.
Further Reading
- Five stocks we like better than Primary Health Properties
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Primary Health Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Primary Health Properties and related companies with MarketBeat.com's FREE daily email newsletter.
